Skip to content

Alogliptin

Alogliptin (Nesina) is a DPP-4 inhibitor used for type 2 diabetes. This catalogue lists Nesina, a single-ingredient tablet.

Nesina

Type 2 Diabetes Mellitus

12.5mg · 25mg

Alogliptin tablets for type 2 diabetes. It helps the body release more insulin when blood sugar rises after eating.

From$1.08/ tabletView

Key points

  • By blocking DPP-4, alogliptin prolongs incretin activity, so insulin release is linked to blood glucose levels.
  • Official information gives specific attention to pancreatitis symptoms and a history of heart failure.

Nesina in this catalogue

Nesina is the single-ingredient alogliptin tablet listed for Type 2 Diabetes Mellitus. It appears in 12.5mg and 25mg strengths within Diabetes Management, and Takeda is identified as its originator.

Further reading